High-grade serous ovarian cancer is the most common and aggressive form of ovarian cancer and often becomes resistant to ...

A new discovery from UC San Diego researchers could enable easier treatment of high-grade serous ovarian cancer, the most common and aggressive form of ovarian cancer.

Explore new findings on ovarian cancer and how blocking focal adhesion kinase can enhance immune response in treatment.

Researchers have developed a human intestinal cell model that closely mimics the structure and function of the human gut, enabling more precise prediction of drug-induced gastrointestinal toxicity ...

Growing neurons rely on chemical cues to find their targets, but new research shows that the brain’s physical properties help ...

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that it will report full year 2025 financial results on Monday, March 16, ...

A breakthrough AI system is revolutionizing cancer immunotherapy by enabling scientists to design protein-based keys that train a patient s immune cells to attack cancer with extreme precision. This ...

GSK-J4（AbMole，M5149）是一种特异性抑制组蛋白H3K27me3去甲基化酶的小分子化合物，其作用机制主要通过调控表观遗传修饰影响下游的信号通路。在细胞实验中，GSK-J4对多种肿瘤细胞系表现出显著的增殖抑制作用：在视网膜母细胞瘤中，1- ...